{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:09:03Z","timestamp":1772816943213,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.ijantimicag.2010.11.020","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T09:23:23Z","timestamp":1296897803000},"page":"248-252","source":"Crossref","is-referenced-by-count":22,"title":["Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin"],"prefix":"10.1016","volume":"37","author":[{"given":"J. Ian","family":"Stuart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Milburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deb","family":"Diagre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0005","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM198704093161507","article-title":"Emergence of vancomycin resistance in coagulase-negative staphylococci","volume":"316","author":"Schwalbe","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0015","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1128\/JCM.34.12.3075-3084.1996","article-title":"Identification of staphylococci with a self-educating system using fatty acid analysis and biochemical tests","volume":"34","author":"Behme","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0020","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/JCM.38.2.752-754.2000","article-title":"Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci","volume":"38","author":"Hussain","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0030","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/JCM.28.9.2064-2068.1990","article-title":"Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection","volume":"28","author":"Veach","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0035","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkg130","article-title":"Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000\u20132001","volume":"51","author":"Critchley","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkh198","article-title":"Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar","volume":"53","author":"Johnson","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0050","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2146\/ajhp070080","article-title":"Telavancin: a novel lipoglycopeptide antimicrobial agent","volume":"64","author":"Attwood","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/520429","article-title":"Bacteremia caused by staphylococci with inducible vancomycin heteroresistance","volume":"29","author":"Wong","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2010.05.016","article-title":"Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007\u20132008)","volume":"36","author":"Mendes","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/dki198","article-title":"Telavancin: in vitro activity against staphylococci in a biofilm model","volume":"56","author":"Gander","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.diagmicrobio.2009.10.011","article-title":"Linezolid surveillance program results for 2008 (LEADER Program for 2008)","volume":"65","author":"Farrell","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.020_bib0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.diagmicrobio.2007.10.017","article-title":"Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers","volume":"60","author":"Gales","year":"2008","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T08:56:45Z","timestamp":1592297805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910005364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0924857910005364"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}